卖什么
B2B E-commerce & Fintech platform for Pharmacies & Hospitals in Africa
商业模式拆解
买家：谁掌握预算？
未核实Pharmacy owners and hospital procurement staff in Nigeria/Africa; insurers/HMOs for the benefits-manager product.
触发点：什么让他们现在购买？
Cash tied up in pharmacy stock and risk of cash-flow crunch; need for counterfeit-proof supply without visiting markets or dealing with many sales reps.
工作流：什么输入变成什么输出？
Request inventory finance in the Remedial app, get approval within 24 working hours, buy stock on the Remedial Store with a Pay Later option, receive stock within 24 hours, pay as you dispense.
经济账：省了什么，怎么收费？
未核实Sells 5000+ products (branded, generic, specialty medicines, consumables, small devices) sourced direct from manufacturers/vetted distributors plus inventory financing ("pay ONLY for what you dispense"); revenue likely product margin plus credit fees (fee terms not published).
渠道：怎么接触到客户？
Mobile app (QR code to app store) plus website sign-up; six product modules (Store, Rx, BNPL, Benefits Manager, Intelligence, Market Access) cross-sold to the same providers.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2022 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.